DIN 02552434 — OPZELURA 1.5 %
OPZELURA is a cream of Ruxolitinib (Topical) marketed by INCYTE CORPORATION. The full Ruxolitinib (Topical) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02552434
- Brand name
- OPZELURA
- Active ingredient
- Ruxolitinib (Topical)
- Strength
- 1.5 %
- Dosage form
- CREAM
- Route
- TOPICAL
- Manufacturer
- INCYTE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Topical Janus kinase (JAK) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.